未找到相关数据
Factors impacting treatment with abemaciclib plus endocrine therapy in high risk early-stage HR+/HER2-breast cancer patients
被引：0
作者：
Kudrik, Fred J.
Rosenfeld, Stephan B.
Reganti, Sowjanya
Reddy, Suresh V.
Choksi, Rushir J.
Scott, Jeffrey Alan
Rui, Anna
Sharma, Anubhav
Sura, Teena
Aton, Lindsay
Gart, Mike
Lamb, Ashley
Morere, Lisa
Wang, Brandon
Varughese, Prateesh
Gorantla, Vikram C.
机构：
[1] South Carolina Oncol Associates, W Columbia, SC USA
[2] Highlands Oncol Grp, Fayetteville, AR USA
[3] Canc Care Specialists Reno, Reno, NV USA
[4] Univ Pittsburgh Med Ctr UPMC, Pittsburgh, PA USA
[5] Integra Connect PrecisionQ, W Palm Beach, FL USA
关键词：
D O I：
10.1200/JCO.2025.43.16_suppl.e12521
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：e12521 / e12521
页数：1
相关论文